Deutsche Bank’s ImmuCell ICCC Stock Holding History

Deutsche Bank’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-412	Closed	-$2K	–	4541
2019 Q4	$2K	Buy	+412	New	+$2.13K	﹤0.01%	4828
2018 Q4	–	Sell	-4,500	Closed	-$37K	–	5259
2018 Q3	$37K	Sell	4,500 -100	-2%	-$720	﹤0.01%	4792
2018 Q2	$31K	Buy	4,600 +1,699	+59%	+$12.2K	﹤0.01%	4906
2018 Q1	$20K	Sell	2,901 -2,399	-45%	-$17.6K	﹤0.01%	4994
2017 Q4	$46K	Sell	5,300 -6,600	-55%	-$54K	﹤0.01%	4465
2017 Q3	$77K	Buy	+11,900	New	+$77.9K	﹤0.01%	4252
2017 Q1	–	Sell	-10,363	Closed	-$61K	–	4994
2016 Q4	$61K	Buy	10,363 +6,778	+189%	+$41.3K	﹤0.01%	4292
2016 Q3	$27K	Buy	3,585 +1,800	+101%	+$13.1K	﹤0.01%	4438
2016 Q2	$12K	Buy	1,785 +700	+65%	+$4.73K	﹤0.01%	4880
2016 Q1	$7K	Buy	+1,085	New	+$7.23K	﹤0.01%	4898
2015 Q4	–	Sell	-1,300	Closed	-$7K	–	5330
2015 Q3	$7K	Buy	+1,300	New	+$10.6K	﹤0.01%	5004

Other funds holding ICCC

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SRC

Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank's ICCC Position: Q1 2020 in Review

Deutsche Bank sold out of ImmuCell (ICCC) in Q1 2020, closing a stake of 412 shares — an estimated $2K sold.

Deutsche Bank first reported a position in ICCC in Q3 2015 and held it in 11 quarters. The position peaked at $77K in Q3 2017. 21 funds tracked by Wall St. Rank hold ICCC as of Q1 2020.

Deutsche Bank reported no remaining ImmuCell position as of Q1 2020 after selling out during the quarter.
Deutsche Bank sold 412 ImmuCell shares in Q1 2020, an estimated $2K.
Deutsche Bank first reported a position in ImmuCell in Q3 2015 and held it in 11 quarters.
Deutsche Bank's ImmuCell position peaked at $77K in Q3 2017.
21 funds tracked by Wall St. Rank held ImmuCell as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.